Why the study?
Immediate results of mitral valve surgery in patients with severe pulmonary hypertension with versus without concomitant pulmonary artery denervation were compared to assess potential benefits.
Does concomitant radiofrequency pulmonary artery ablation reduce pulmonary artery pressure in patients with mitral valve disease and severe pulmonary hypertension undergoing mitral valve surgery?
RCT (n=30)
Does concomitant radiofrequency pulmonary artery ablation reduce pulmonary artery pressure in patients with mitral valve disease and severe pulmonary hypertension undergoing mitral valve surgery?
Absolute Event Rate: 48% vs 59%
p-value: p=<0.05
Concomitant pulmonary artery denervation during mitral valve surgery significantly reduces early postoperative pulmonary artery pressure in patients with severe Group 2 pulmonary hypertension.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bogachev-Prokophiev et al. (2017) conducted an RCT in Severe pulmonary hypertension and mitral valve disease (n=30). Concomitant pulmonary artery ablation vs. Mitral valve surgery alone was evaluated on Systolic pulmonary artery pressure on the third day after surgery (mm Hg) (p=<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: